Skip to content

Myocardial Infarction Register of the Saarland

Myokardinfarkt-Register Des Saarlandes (MIR-SL)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02961985
Acronym
MIR-SL
Enrollment
455
Registered
2016-11-11
Start date
2016-10-31
Completion date
2023-03-29
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Brief summary

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.

Detailed description

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland. In order to obtain representative data for the Saarland, preferably all consecutive patients should be documented comprehensively in the University Hospital of the Saarland, the non-university hospitals with cardiac catheterization laboratory as well as in hospitals without cardiac catheterization laboratory . MIR-SL is attended by all 22 hospitals in Saarland, that treat patients with acute STEMI. A follow-up will be carried out after three months, 12 months and five years.

Interventions

None listed

Sponsors

Ministry of Social Affairs, Health, Women and Family of Saarland
CollaboratorUNKNOWN
Stiftung Institut fuer Herzinfarktforschung
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* signed informed consent

Exclusion criteria

* age \< 18 years * missing informed consent

Design outcomes

Primary

MeasureTime frameDescription
Rate of reperfusion therapies24 hoursDescribe hospital daily routine in Germany

Secondary

MeasureTime frameDescription
Time before reperfusion therapy24 hourspre-hospital time, intrahospital time, transfer time
In-hospital mortality24 hoursDescribe mortality before discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026